Fisher & Paykel Healthcare Corporation Ltd
NZX:FPH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Fisher & Paykel Healthcare Corporation Ltd
NZX:FPH
|
NZ |
|
Strongpoint ASA
F:PGT
|
NO |
|
AiroLam Ltd
NSE:AIROLAM
|
IN |
|
H
|
H&R GmbH & Co KgaA
XHAM:2HRA
|
DE |
|
El En SpA
F:EE5
|
IT |
|
S
|
Sturm Ruger & Company Inc
SWB:ST2
|
US |
|
Metro Holdings Ltd
SGX:M01
|
SG |
Intrinsic Value
Is FPH undervalued or overvalued?
See the intrinsic value estimate for Fisher & Paykel Healthcare Corporation Ltd and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Fisher & Paykel Healthcare Does
Fisher & Paykel Healthcare makes medical devices that help patients breathe more comfortably. Its main products include hospital systems for breathing support, heated humidification equipment, and sleep apnea therapy devices for home use. The company also supplies masks, tubing, and other disposable parts that are used with these systems.
- Headquarters
- New Zealand NZ
- Employees
- 7 506
- IPO date
- Nov 13, 2001
Fisher & Paykel Healthcare has a narrow economic moat
Hospitals using F&P systems also buy associated disposable supplies, and changing systems can mean replacing equipment and retraining staff. Patents protect some product designs, though established rivals such as ResMed and Philips in sleep and breathing care, and Vapotherm in high-flow therapy, offer alternatives.
Read the full moat analysis
Earnings Waterfall
Fisher & Paykel Healthcare Corporation Ltd
The intrinsic value for Fisher & Paykel Healthcare Corporation Ltd (FPH) under the Base Case is hidden NZD.
Compared with the current market price of 47.57 NZD, the stock appears hidden.